Nuclear_JJ
factor_NN
kappa_NN
B_NN
activates_VBZ
proenkephalin_NN
transcription_NN
in_IN
T_NN
lymphocytes_NNS
._.

Upon_IN
activation_NN
,_,
T_NN
lymphocytes_NNS
accumulate_VBP
high_JJ
levels_NNS
of_IN
the_DT
neuropeptide_NN
enkephalin_NN
which_WDT
correlate_VBP
with_IN
high_JJ
levels_NNS
of_IN
proenkephalin_NN
mRNA_NN
in_IN
the_DT
cells_NNS
._.

Here_RB
we_PRP
investigated_VBD
the_DT
transcriptional_JJ
basis_NN
for_IN
these_DT
changes_NNS
._.

The_DT
proenkephalin_NN
promoter_NN
contains_VBZ
a_DT
sequence_NN
GGGGACGTCCCC_NN
,_,
named_VBN
B2_NN
,_,
which_WDT
is_VBZ
similar_JJ
to_TO
the_DT
kappa_NN
B_NN
sequence_NN
GGGGACTTTCC_NN
,_,
the_DT
binding_VBG
site_NN
of_IN
the_DT
transcription_NN
factor_NN
nuclear_JJ
factor_NN
-LRB-_-LRB-
NF_NN
-RRB-_-RRB-
-_:
kappa_NN
B_NN
._.

Activation_NN
of_IN
T_NN
lymphocytes_NNS
induces_VBZ
an_DT
NF-kappa_NN
B-like_JJ
binding_NN
activity_NN
to_TO
the_DT
B2_NN
site_NN
,_,
concomitant_JJ
with_IN
activation_NN
of_IN
the_DT
proenkephalin_NN
promoter_NN
._.

Mutations_NNS
at_IN
the_DT
B2_NN
site_NN
abolish_VBP
this_DT
transcriptional_JJ
activation_NN
._.

The_DT
purified_VBN
homodimer_NN
-LRB-_-LRB-
two_CD
p50s_NNS
-RRB-_-RRB-
of_IN
the_DT
DNA-binding_JJ
subunit_NN
of_IN
NF-kappa_NN
B_NN
binds_VBZ
the_DT
B2_NN
site_NN
of_IN
proenkephalin_NN
relatively_RB
better_JJR
than_IN
does_VBZ
the_DT
heterotetramer_NN
-LRB-_-LRB-
two_CD
p65s_NNS
plus_CC
two_CD
p50s_NNS
-RRB-_-RRB-
form_NN
of_IN
the_DT
factor_NN
._.

Thus_RB
,_,
it_PRP
appears_VBZ
that_IN
the_DT
T-cell-specific_JJ
activation_NN
of_IN
the_DT
proenkephalin_NN
promoter_NN
is_VBZ
mediated_VBN
by_IN
NF-kappa_NN
B_NN
._.

However_RB
,_,
as_IN
NF-kappa_NN
B_NN
is_VBZ
ubiquitous_JJ
and_CC
the_DT
transcriptional_JJ
activation_NN
through_IN
the_DT
B2_NN
site_NN
is_VBZ
T_NN
cell_NN
specific_JJ
,_,
yet_CC
another_DT
T-cell-specific_JJ
factor_NN
which_WDT
synergizes_VBZ
with_IN
NF-kappa_NN
B_NN
should_MD
be_VB
considered_VBN
._.

